BIOLASE, Inc. (NASDAQ:BIOL – Get Free Report)’s stock price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.01 and traded as high as $0.02. BIOLASE shares last traded at $0.01, with a volume of 35,749 shares changing hands.
Analyst Ratings Changes
Separately, StockNews.com began coverage on shares of BIOLASE in a report on Friday. They set a “sell” rating on the stock.
Check Out Our Latest Research Report on BIOLASE
BIOLASE Stock Down 16.8 %
About BIOLASE
BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.
Further Reading
- Five stocks we like better than BIOLASE
- Top Biotech Stocks: Exploring Innovation Opportunities
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- Should You Invest in Penny Stocks?
- Top 3 Beverage Stocks Pouring Out Profits
- The Role Economic Reports Play in a Successful Investment Strategy
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for BIOLASE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIOLASE and related companies with MarketBeat.com's FREE daily email newsletter.
